{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:08:28Z","timestamp":1747156108026,"version":"3.40.5"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bbr.2021.113585","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T01:22:45Z","timestamp":1631755365000},"page":"113585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Blockade of adenosine A2A receptors inhibits Tremulous Jaw Movements as well as expression of zif-268 and GAD65 mRNAs in brain motor structures"],"prefix":"10.1016","volume":"417","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4581-6196","authenticated-orcid":false,"given":"Barbara","family":"Kosmowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8381-6632","authenticated-orcid":false,"given":"Krystyna","family":"Ossowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0208-1946","authenticated-orcid":false,"given":"Jadwiga","family":"Wardas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2021.113585_bib1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0037-1601558","article-title":"Pathophysiology and management of Parkinsonian tremor","volume":"37","author":"Helmich","year":"2017","journal-title":"Semin. Neurol."},{"issue":"Suppl 5","key":"10.1016\/j.bbr.2021.113585_bib2","doi-asserted-by":"crossref","first-page":"V33","DOI":"10.1007\/PL00007781","article-title":"The pathophysiology of parkinsonian tremor: a review","volume":"247","author":"Deuschl","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbr.2021.113585_bib3","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/jamaneurol.2015.2397","article-title":"Basal Ganglia circuits as targets for neuromodulation in Parkinson disease","volume":"72","author":"deLong","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbr.2021.113585_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0166-2236(92)90355-C","article-title":"The neostriatal mosaic: multiple levels of compartmental organization","volume":"15","author":"Gerfen","year":"1992","journal-title":"Trends Neurosci."},{"issue":"7","key":"10.1016\/j.bbr.2021.113585_bib5","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1111\/ejn.14777","article-title":"Shedding lights on dyskinesia","volume":"53","author":"Castela","year":"2021","journal-title":"Eur. J. Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.bbr.2021.113585_bib6","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/S1353-8020(11)70027-X","article-title":"Parkinson\u2019s disease tremor: pathophysiology","volume":"18","author":"Hallett","year":"2012","journal-title":"Park. Relat. Disord."},{"issue":"2","key":"10.1016\/j.bbr.2021.113585_bib7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/mds.27224","article-title":"The cerebral basis of Parkinsonian tremor: a network perspective","volume":"33","author":"Helmich","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2021.113585_bib8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0301-0082(98)00053-7","article-title":"Tremulous jaw movements in rats; a model of Parkinsonian tremor","volume":"56","author":"Salamone","year":"1998","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbr.2021.113585_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0091-3057(96)00225-0","article-title":"Tremulous jaw movements produced by acute tacrine administration: possible relation to parkinsonian side effects","volume":"56","author":"Mayorga","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2021.113585_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pbb.2009.07.001","article-title":"Differential effects of adenosine antagonists in two models of parkinsonian tremor","volume":"94","author":"Trevitt","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.bbr.2021.113585_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00213-002-1247-3","article-title":"Local injections of the 5-hydroxytryptamine antagonist mianserin into substantia nigra pars reticulata block tremulous jaw movements in rats: studies with a putative model of Parkinsonian tremor","volume":"165","author":"Carlson","year":"2003","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.bbr.2021.113585_bib12","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0306-4522(03)00218-5","article-title":"Brain implantations of engineered GABA-releasing cells suppress tremor in an animal model of Parkinsonism","volume":"119","author":"Carlson","year":"2003","journal-title":"Neuroscience"},{"issue":"25","key":"10.1016\/j.bbr.2021.113585_bib13","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1055\/s-2008-1069311","article-title":"Wirkungen oraler Memantin-Gaben auf die Parkinson-symptomatik: ergebnisse einer placebo-kontrollierten multicenter-studie","volume":"109","author":"Schneider","year":"1984","journal-title":"Dtsch. Med. Wochenschr."},{"issue":"4","key":"10.1016\/j.bbr.2021.113585_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF02260076","article-title":"Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson\u2019s disease","volume":"4","author":"Rabey","year":"1992","journal-title":"J. Neural Transm. PD Dement. Sect."},{"issue":"7","key":"10.1016\/j.bbr.2021.113585_bib15","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1111\/bph.14914","article-title":"Neuroanatomical correlates of the inhibition of tremulous jaw movements in rats by a combination of memantine and \u0394 9 \u2013tetrahydrocannabinol","volume":"177","author":"Ionov","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2021.113585_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ana.22361","article-title":"Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor","volume":"69","author":"Helmich","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbr.2021.113585_bib17","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1093\/brain\/aws023","article-title":"Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits?","volume":"135","author":"Helmich","year":"2012","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.bbr.2021.113585_bib18","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1212\/WNL.51.3.803","article-title":"The metabolic anatomy of tremor in Parkinson\u2019s disease","volume":"51","author":"Antonini","year":"1998","journal-title":"Neurology"},{"issue":"18","key":"10.1016\/j.bbr.2021.113585_bib19","doi-asserted-by":"crossref","first-page":"8452","DOI":"10.1073\/pnas.1000496107","article-title":"The basal ganglia communicate with the cerebellum","volume":"107","author":"Bostan","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2021.113585_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fnsys.2011.00049","article-title":"Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor","volume":"5","author":"Collins-Praino","year":"2011","journal-title":"Front. Syst. Neurosci."},{"issue":"3","key":"10.1016\/j.bbr.2021.113585_bib21","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.2741\/2952","article-title":"Tremorolytic effects of adenosine A2A antagonists: implications for parkinsonism","volume":"13","author":"Salamone","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bbr.2021.113585_bib22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbr.2015.11.008","article-title":"The MAO-B inhibitor deprenyl reduces the oral tremor and the dopamine depletion induced by the VMAT-2 inhibitor tetrabenazine","volume":"298","author":"Podurgiel","year":"2016","journal-title":"Behav. Brain Res."},{"issue":"2\u20133","key":"10.1016\/j.bbr.2021.113585_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(97)00008-3","article-title":"Tremulous jaw movements induced by the acetylcholinesterase inhibitor tacrine: effects of antiparkinsonian drugs","volume":"322","author":"Cousins","year":"1997","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2021.113585_bib24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bbr.2004.05.019","article-title":"Dopamine agonists suppress cholinomimetic-induced tremulous jaw movements in an animal model of Parkinsonism: tremorolytic effects of pergolide, ropinirole and CY 208-243","volume":"156","author":"Salamone","year":"2005","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.bbr.2021.113585_bib25","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1111\/ejn.12212","article-title":"Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism","volume":"38","author":"Collins-Praino","year":"2013","journal-title":"Eur. J. Neurosci."},{"issue":"3","key":"10.1016\/j.bbr.2021.113585_bib26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1212\/01.WNL.0000073136.00548.D4","article-title":"A(2A) receptor antagonist treatment of Parkinson\u2019s disease","volume":"61","author":"Bara-Jimenez","year":"2003","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.bbr.2021.113585_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.pneurobio.2007.07.001","article-title":"Role of adenosine A2A receptors in parkinsonian motor impairment and L-DOPA-induced motor complications","volume":"83","author":"Morelli","year":"2007","journal-title":"Prog. Neurobiol."},{"issue":"8","key":"10.1016\/j.bbr.2021.113585_bib28","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00702-018-1848-6","article-title":"Role of adenosine A2A receptors in motor control: relevance to Parkinson\u2019s disease and dyskinesia","volume":"125","author":"Pinna","year":"2018","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"3","key":"10.1016\/j.bbr.2021.113585_bib29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/14737175.2021.1880896","article-title":"Istradefylline - a first generation adenosine A2A antagonist for the treatment of Parkinson\u2019s disease","volume":"21","author":"Jenner","year":"2021","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bbr.2021.113585_bib30","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3389\/fphar.2018.01200","article-title":"PBF509, an adenosine A 2A receptor antagonist with efficacy in rodent models of movement disorders","volume":"9","author":"Nunez","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbr.2021.113585_bib31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2018.05.033","article-title":"Remote control of movement disorders using a photoactive adenosine A 2A receptor antagonist","volume":"283","author":"Taura","year":"2018","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.bbr.2021.113585_bib32","first-page":"398","article-title":"The non-xanthine heterocyclic compound SCH58261 is a new potent and selective A2a adenosine receptor antagonist","volume":"276","author":"Zocchi","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2\u20133","key":"10.1016\/j.bbr.2021.113585_bib33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0163-7258(01)00139-5","article-title":"Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs","volume":"90","author":"Joyce","year":"2001","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbr.2021.113585_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001949","article-title":"Cochrane database of systematic reviews: reviews!Pimozide for schizophrenia or related psychoses","author":"Sultana","year":"2000","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbr.2021.113585_bib35","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0197-0186(96)00136-2","article-title":"Egr transcription factors in the nervous system","volume":"31","author":"Beckmann","year":"1997","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbr.2021.113585_bib36","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.1073\/pnas.88.12.5106","article-title":"Constitutive expression of zif268 in neocortex is regulated by synaptic activity","volume":"88","author":"Worley","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2021.113585_bib37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fnbeh.2018.00079","article-title":"Immediate early genes, memory and psychiatric disorders: focus on c-Fos, Egr1 and Arc","volume":"12","author":"Gallo","year":"2018","journal-title":"Front. Behav. Neurosci."},{"issue":"4","key":"10.1016\/j.bbr.2021.113585_bib38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pneurobio.2004.05.007","article-title":"A gene for neuronal plasticity in the mammalian brain: Zif268\/Egr-1\/NGFI-A\/Krox-24\/TIS8\/ZENK?","volume":"74","author":"Knapska","year":"2004","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.bbr.2021.113585_bib39","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.tins.2003.11.005","article-title":"VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate","volume":"27","author":"Fremeau Jr","year":"2004","journal-title":"Trends Neurosci."},{"issue":"12","key":"10.1016\/j.bbr.2021.113585_bib40","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s12272-019-01196-z","article-title":"The regulation of glutamic acid decarboxylases in GABA neurotransmission in the brain","volume":"42","author":"Lee","year":"2019","journal-title":"Arch. Pharm. Res."},{"issue":"7","key":"10.1016\/j.bbr.2021.113585_bib41","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1007\/s12035-020-01912-7","article-title":"Molecular, structural, functional, and pharmacological sites for vesicular glutamate transporter regulation","volume":"57","author":"Pietrancosta","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"6801","key":"10.1016\/j.bbr.2021.113585_bib42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/35025070","article-title":"Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons","volume":"407","author":"Takamori","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2021.113585_bib43","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1523\/JNEUROSCI.3003-04.2005","article-title":"Presynaptic regulation of quantal size by the vesicular glutamate transporter VGLUT1","volume":"25","author":"Wilson","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2021.113585_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnsyn.2016.00002","article-title":"Presynaptic molecular determinants of quantal size","volume":"8","author":"Takamori","year":"2016","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.bbr.2021.113585_bib45","doi-asserted-by":"crossref","first-page":"7158","DOI":"10.1073\/pnas.0401764101","article-title":"An essential role for vesicular glutamate transporter 1 (VGLUT1) in postnatal development and control of quantal size","volume":"101","author":"Wojcik","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2021.113585_bib46","doi-asserted-by":"crossref","first-page":"11781","DOI":"10.1523\/JNEUROSCI.1444-14.2014","article-title":"Vesicular glutamate transporter expression level affects synaptic vesicle release probability at hippocampal synapses in culture","volume":"34","author":"Herman","year":"2014","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.bbr.2021.113585_bib47","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.pbb.2004.12.006","article-title":"Validation of the tremulous jaw movement model for assessment of the motor effects of typical and atypical antipychotics: effects of pimozide (Orap) in rats","volume":"80","author":"Ishiwari","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2021.113585_bib48","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.expneurol.2004.05.027","article-title":"Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions","volume":"189","author":"Simola","year":"2004","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.bbr.2021.113585_bib49","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/syn.1070","article-title":"SCH58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats","volume":"41","author":"Wardas","year":"2001","journal-title":"Synapse"},{"issue":"3","key":"10.1016\/j.bbr.2021.113585_bib50","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11302-020-09716-z","article-title":"Involvement of adenosine A1 and A2A receptors on guanosine-mediated anti-tremor effects in reserpinized mice","volume":"16","author":"Massari","year":"2020","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.bbr.2021.113585_bib51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bbr.2015.04.001","article-title":"Adenosine A2A receptor-mediated control of pilocarpine-induced tremulous jaw movements is Parkinson\u2019s disease-associated GPR37 receptor-dependent","volume":"288","author":"Gandia","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"4","key":"10.1016\/j.bbr.2021.113585_bib52","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.pbb.2009.11.011","article-title":"Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX","volume":"94","author":"Collins","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"7","key":"10.1016\/j.bbr.2021.113585_bib53","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1007\/s11064-020-03010-5","article-title":"Pramipexole reduces zif-268 mRNA expression in brain structures involved in the generation of harmaline-induced tremor","volume":"45","author":"Kosmowska","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbr.2021.113585_bib54","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuroscience.2019.12.045","article-title":"Inhibition of excessive glutamatergic transmission in the ventral thalamic nuclei by a selective adenosine A1 receptor agonist, 5\u2032-Chloro-5\u2032-Deoxy-(\u00b1)-ENBA underlies its tremorolytic effect in the harmaline-induced model of essential tremor","volume":"429","author":"Kosmowska","year":"2020","journal-title":"Neuroscience"},{"year":"2007","series-title":"The Rat Brain","author":"Paxinos","key":"10.1016\/j.bbr.2021.113585_bib55"},{"key":"10.1016\/j.bbr.2021.113585_bib56","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00165392","article-title":"Zona Incerta-lateral hypothalamus as an output structure for impulses involved in neuroleptic drug-induced catalepsy","volume":"347","author":"Ossowska","year":"1993","journal-title":"Naunyn-Schmied. Arch. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbr.2021.113585_bib57","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s12640-013-9446-8","article-title":"A critical evaluation of behavioral rodent models of motor impairment used for screening of antiparkinsonian activity: the case of adenosine A(2A) receptor antagonists","volume":"25","author":"Pinna","year":"2014","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbr.2021.113585_bib58","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3389\/fnbeh.2017.00240","article-title":"Immediate-early genes modulation by antipsychotics: translational implications for a putative gateway to drug-induced long-term brain changes","volume":"11","author":"de Bartolomeis","year":"2017","journal-title":"Front. Behav. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.bbr.2021.113585_bib59","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0091-3057(96)00385-1","article-title":"Tremulous characteristics of the vacuous jaw movements induced by pilocarpine and ventrolateral striatal dopamine depletions","volume":"57","author":"Finn","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.bbr.2021.113585_bib60","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0306-4522(89)90128-0","article-title":"The organization of the projection from the cerebral cortex to the striatum in the rat","volume":"29","author":"McGeorge","year":"1989","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.bbr.2021.113585_bib61","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"Neurol. Sci."},{"issue":"3","key":"10.1016\/j.bbr.2021.113585_bib62","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0091-3057(98)00214-7","article-title":"The role of ventrolateral striatal acetylcholine in the production of tacrine-induced jaw movements","volume":"62","author":"Cousins","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2021.113585_bib63","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1749-6632.1999.tb09264.x","article-title":"Functional-anatomical implications of the nucleus accumbens core and shell subterritories","volume":"877","author":"Zahm","year":"1999","journal-title":"Ann. NY Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bbr.2021.113585_bib64","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbr.2012.06.011","article-title":"Extracelullar GABA in globus pallidus increases during the induction of oral tremor by haloperidol but not by muscarinic receptor stimulation","volume":"234","author":"Collins-Praino","year":"2012","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.bbr.2021.113585_bib65","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s00213-003-1521-z","article-title":"Motor effects of GABA(A) antagonism in globus pallidus: studies of locomotion and tremulous jaw movements in rats","volume":"170","author":"Wisniecki","year":"2003","journal-title":"Psychopharmacol. (Berl. )"},{"issue":"2","key":"10.1016\/j.bbr.2021.113585_bib66","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1046\/j.1460-9568.2000.00968.x","article-title":"Basal expression of c-Fos and Zif268 in the rat basal ganglia: immunohistochemical characterization of striatal Zif268-positive neurons","volume":"12","author":"Ishida","year":"2000","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.bbr.2021.113585_bib67","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0168-0102(02)00027-5","article-title":"Functional significance of the cortico-subthalamo-pallidal \u2018hyperdirect\u2019 pathway","volume":"43","author":"Nambu","year":"2002","journal-title":"Neurosci. Res."},{"issue":"4","key":"10.1016\/j.bbr.2021.113585_bib68","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.neuroscience.2003.10.043","article-title":"Stimulation of adenosine A2A receptors elicits zif\/268 and NMDA epsilon2 subunit mRNA expression in cortex and striatum of the \u201cweaver\u201d mutant mouse, a genetic model of nigrostriatal dopamine deficiency","volume":"123","author":"Ekonomou","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2021.113585_bib69","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1016\/j.neubiorev.2013.09.008","article-title":"Critical involvement of the motor cortex in the pathophysiology and treatment of Parkinson\u2019s disease","volume":"37","author":"Lindenbach","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbr.2021.113585_bib70","doi-asserted-by":"crossref","first-page":"S548","DOI":"10.1002\/mds.22062","article-title":"Functional organization of the Basal Ganglia: therapeutic implications for Parkinson\u2019s Disease","volume":"Suppl. 3","author":"Obeso","year":"2008","journal-title":"Mov. Dis. 23"},{"issue":"3","key":"10.1016\/j.bbr.2021.113585_bib71","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0306-4522(98)00241-3","article-title":"Enkephalin regulates acute D2 dopamine receptor antagonist-induced immediate-early gene expression in striatal neurons","volume":"88","author":"Steiner","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2021.113585_bib72","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0893-133X(98)00051-7","article-title":"Involvement of adenosine A2A receptors in the induction of c-Fos expression by clozapine and haloperidol","volume":"20","author":"Pinna","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2021.113585_bib73","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bbr.2013.03.035","article-title":"Effect of subtype-selective adenosine receptor antagonists on basal or haloperidol-regulated striatal function: studies of exploratory locomotion and c-Fos immunoreactivity in outbred and A(2A)R KO mice","volume":"247","author":"Pardo","year":"2013","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.bbr.2021.113585_bib74","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0306-4522(98)00364-9","article-title":"Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-HT4 or 5-HT6 receptors following antipsychotic administration","volume":"89","author":"Ward","year":"1999","journal-title":"Neuroscience"},{"issue":"20","key":"10.1016\/j.bbr.2021.113585_bib75","doi-asserted-by":"crossref","first-page":"8038","DOI":"10.1523\/JNEUROSCI.17-20-08038.1997","article-title":"Dopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression","volume":"17","author":"Le Moine","year":"1997","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bbr.2021.113585_bib76","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0006-8993(97)00214-X","article-title":"Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas","volume":"759","author":"Pinna","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2021.113585_bib77","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0306-4522(97)00046-8","article-title":"Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens","volume":"79","author":"Svenningsson","year":"1997","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.bbr.2021.113585_bib78","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0006-8993(93)91204-6","article-title":"Differential localization of A2a adenosine receptor mRNA with D1 and D2 dopamine receptor mRNA in striatal output pathways following a selective lesion of striatonigral neurons","volume":"631","author":"Pollack","year":"1993","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.bbr.2021.113585_bib79","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/med.21432","article-title":"Potential therapeutic applications of adenosine A2A receptor ligands and opportunities for A2A receptor imaging","volume":"38","author":"van Waarde","year":"2018","journal-title":"Med. Res. Rev."},{"issue":"2","key":"10.1016\/j.bbr.2021.113585_bib80","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/(SICI)1096-9861(19981116)401:2<163::AID-CNE2>3.0.CO;2-D","article-title":"Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system","volume":"401","author":"Rosin","year":"1998","journal-title":"J. Comp. Neurol."},{"issue":"6","key":"10.1016\/j.bbr.2021.113585_bib81","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1476-5381.1996.tb15561.x","article-title":"Tissue distribution of adenosine receptor mRNAs in the rat","volume":"118","author":"Dixon","year":"1996","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbr.2021.113585_bib82","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(99)00011-8","article-title":"Distribution, biochemistry and function of striatal adenosine A2A receptors","volume":"59","author":"Svenningsson","year":"1999","journal-title":"Prog. Neurobiol."},{"issue":"6","key":"10.1016\/j.bbr.2021.113585_bib83","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/sj.bjp.0705692","article-title":"Binding of the prototypical adenosine A(2A) receptor agonist CGS 21680 to the cerebral cortex of adenosine A(1) and A(2A) receptor knockout mice","volume":"141","author":"Lopes","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2021.113585_bib84","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0304-3940(00)01371-9","article-title":"A(2A) receptor mRNA expression in Parkinson\u2019s disease","volume":"291","author":"Hurley","year":"2000","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.bbr.2021.113585_bib85","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/cne.22751","article-title":"Adenosine A2A receptor in the monkey basal ganglia: ultrastructural localization and colocalization with the metabotropic glutamate receptor 5 in the striatum","volume":"520","author":"Bogenpohl","year":"2012","journal-title":"J. Comp. Neurol."},{"issue":"3","key":"10.1016\/j.bbr.2021.113585_bib86","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/1096-9861(20010312)431:3<331::AID-CNE1074>3.0.CO;2-W","article-title":"Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum","volume":"431","author":"Hettinger","year":"2001","journal-title":"J. Comp. Neurol."},{"issue":"20","key":"10.1016\/j.bbr.2021.113585_bib87","doi-asserted-by":"crossref","first-page":"8794","DOI":"10.1523\/JNEUROSCI.2989-12.2013","article-title":"FACS array profiling identifies Ecto-5\u2032 nucleotidase as a striatopallidal neuron-specific gene involved in striatal-dependent learning","volume":"33","author":"Ena","year":"2013","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.bbr.2021.113585_bib88","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1523\/JNEUROSCI.3574-05.2006","article-title":"Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers","volume":"26","author":"Ciruela","year":"2006","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.bbr.2021.113585_bib89","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1523\/JNEUROSCI.5255-07.2008","article-title":"A critical role of the adenosine A2A receptor in extrastriatal neurons in modulating psychomotor activity as revealed by opposite phenotypes of striatum and forebrain A2A receptor knock-outs","volume":"28","author":"Shen","year":"2008","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.bbr.2021.113585_bib90","doi-asserted-by":"crossref","first-page":"80902","DOI":"10.1371\/journal.pone.0080902","article-title":"Adenosine A\u2082A receptors in striatal glutamatergic terminals and GABAergic neurons oppositely modulate psychostimulant action and DARPP-32 phosphorylation","volume":"8","author":"Shen","year":"2013","journal-title":"PLoS One"},{"issue":"5890","key":"10.1016\/j.bbr.2021.113585_bib91","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.1160575","article-title":"Dichotomous dopaminergic control of striatal synaptic plasticity","volume":"321","author":"Shen","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.bbr.2021.113585_bib92","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.nbd.2014.08.006","article-title":"Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models","volume":"71","author":"Thiele","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.bbr.2021.113585_bib93","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neuroscience.2004.04.050","article-title":"Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson\u2019s disease","volume":"127","author":"Ochi","year":"2004","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.bbr.2021.113585_bib94","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.2174\/156802611795347564","article-title":"The role of extracellular adenosine in chemical neurotransmission in the hippocampus and Basal Ganglia: pharmacological and clinical aspects","volume":"11","author":"Sperlagh","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"issue":"2","key":"10.1016\/j.bbr.2021.113585_bib95","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0306-4522(97)00087-0","article-title":"Involvement of pallidal and nigral GABA mechanisms in the generation of tremulous jaw movements in rats","volume":"80","author":"Finn","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2021.113585_bib96","doi-asserted-by":"crossref","first-page":"02397","DOI":"10.7554\/eLife.02397","article-title":"The inhibitory microcircuit of the substantia nigra provides feedback gain control of the basal ganglia output","volume":"3","author":"Brown","year":"2014","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.bbr.2021.113585_bib97","first-page":"268","article-title":"Haloperidol-increased muscle tone in rats as a model of parkinsonian rigidity","volume":"109","author":"Lorenc-Koci","year":"1996","journal-title":"Brain Res."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432821004733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432821004733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T17:07:57Z","timestamp":1717693677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432821004733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":97,"alternative-id":["S0166432821004733"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2021.113585","relation":{},"ISSN":["0166-4328"],"issn-type":[{"type":"print","value":"0166-4328"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blockade of adenosine A2A receptors inhibits Tremulous Jaw Movements as well as expression of zif-268 and GAD65 mRNAs in brain motor structures","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2021.113585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113585"}}